Wondering how an integrated risk management solution incorporates education, process, and technology? Are you curious about how AI can enhance your daily tasks in clinical trials? If so, we invite you to join us at the SCOPE Summit 2024.
In this blog post, Keith Dorricott, our lead instructor at MyRBQM Academy, takes us on a reflective journey through the mindsON RBQM series. From its inception to its evolution and impact on over 1000 participants across 150 companies, Keith shares his insights and experiences.
Explore the impact of ICH's Q9(R1), Quality Risk Management, guideline on RBQM and clinical trials in our latest blog post. Don't miss our free infographic that simplifies this complex guideline. Enhance your risk strategies today!
Our MyRBQM Functional Service Provision model redefines FSP models in clinical trials with its unique, independent RBQM solutions. It offers integrated risk management strategies, AI-augmented tools like the MyRBQM Portal, and specialized training through the MyRBQM Academy, setting new industry standards.
We proudly present our virtual dialogue on Responsible AI in Clinical Trials this November 15 & 16, uniting industry and academic experts for groundbreaking discussions and insights.
In a fast-changing pharma landscape, our MyRBQM® Portal transforms clinical trial and pipeline oversight and aids in M&A due diligence, offering a strategic edge in compliance and growth.
Enhancing Clinical Trial Risk Management: A Response to the Growing Concerns over Fraudulent Studies
In this blog, we explore the growing concerns about fraudulent RCTs highlighted in a recent Nature article. Discover how innovative risk management approaches can detect, prevent, and tackle these issues, facilitating more robust regulatory oversight.
MyRBQM Portal has made its debut on the Azure Marketplace. This milestone allows biopharmaceutical companies to streamline and unify their approach to risk management by using the secure and reliable Azure cloud platform.
Discover how Decentralized Clinical Trials (DCTs) have the potential to reshape oncology care. Using our eyesON DCT Outlook, we reveal how patient demographics, broadband internet, and registered oncologists could drive DCT opportunities and potentially enhance cancer survivorship.
Be prepared for ICH E6(R3): turn guidelines into real-world action. In this post, we delve into the key updates and training gaps.